Vaccines: How Protection is Elicited?
Adel Mahmoud, Princeton University
Speech at the Herrenhausen Symposium "Dual Use Research on Microbes: Biosafety, Biosecurity, Responsibility", 10.12.2014
The main focus of Adel A. F. Mahmoud’s talk is out on vaccines, their value, use, and still limited knowledge of the underlying biological processes. He describes the dual nature of immune responses in general as well as current assessments of influenza vaccines in particular. Mahmoud is a Professor at Princeton University and has recently retired as President of Merck Vaccines. Prior to that, he served at Case Western Reserve University and University Hospitals of Cleveland as chairman of medicine and physician-in-chief. Dr. Mahmoud's academic pursuits focused on investigations of host resistance to infections. At Merck, he led the effort to develop four new vaccines including: combination of Measles, Mumps, Rubella and Varicella; Rota Virus; Shingles; Human Papillomavirus. He is a member of the Institute of Medicine of the National Academy of Sciences and is a past president of the International Society for Infectious Diseases.
Photo: David Carreno Hansen for Volkswagen Foundation
ScienceUncut - Science Podcast by Volkswagen Foundation